Annual Report & ACCOUNTS for the year ended 30 June 2014
A key strategic priority for the Group is the delivery and strength of the pipeline. The following chart outlines the timeline, status and progress of the major projects. Collectively the pipeline is expected to deliver in excess of £40 million annual sales assuming all products reach maturity.
(1) Calendar year (2) Osphos (3) Identical product with first launch in EU and subsequent launch in US
The first expected launch date is a management estimate that may not be met due to regulatory, manufacturing or other issues.